GNBT News and Press, Generex Biotechnology From 08/26/20

The NuGenHealth Software as a Service (SaaS) System Remote Patient Monitoring (RPM) Chronic Care Management (CCM) The access information for the investor conference call remains as follows: Direct Toll / International – 1-(866) 831-8711 Domestic US/Canada - 1-(203) 518-9883 P...

The access information for the investor conference call remains as follows: Direct Toll / International – 1-(866) 831-8711 Domestic US/Canada - 1-(203) 518-9883 Program Title: Generex Biotechnology Conference Call Conference ID – 89636 Updated Agenda FDA response to ...

The access information for the investor conference call is as follows:  Direct Toll / International – 1-(866) 831-8711 Domestic US/Canada - 1-(203) 518-9883  Program Title: Generex Biotechnology Conference Call  Conference ID – 89636 Agenda FDA respon...

Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. A podcast of Stocks to Watch is also available on Sundays on Seeking Alpha , Apple ...

Letter of Intent (LOI) signed with potential partners in China to develop the Ii-Key-SARS-CoV-2 vaccine for China with a proposed $5 million upfront payment upon contract signing and minimum of $400 million if the vaccine is proven successful in clinical trials. $20 Million Memorandum of...

Bintai Kinden Corporation Berhad ( www.bintai.com.my ) is an investment holding company headquartered in Malaysia with operations throughout South-East Asia, China, and the Arabian Gulf Region Upfront development payment 100% funding for commercial registration of Ii-Key- SARS-CoV-2 p...

Generex Biotechnology ( OTCQB:GNBT ) has signed a memorandum of understanding with investment holding company Bintai Kinden aimed at funding the development and commercialization of its Ii-Key-SARS-CoV-2 vaccine, what it calls a "complete vaccine" that can potentially induce both T cell ...

Bintai Kinden Corporation Berhad ( www.bintai.com.my ) is an investment holding company headquartered in Malaysia with operations throughout South-East Asia, China, and the Arabian Gulf Region Upfront development payment 100% funding for commercial registration of Ii-Key- SARS-CoV-2 pr...

$20 Million Memorandum of Understanding completed with an investor for a strategic upmarket transaction $10 Million financing proposal in the same MOU for the acquisition of infectious disease and cancer diagnostics company awaiting EUA approval from FDA for COVID-19 rapid diagnostic assa...

A Hybrid Approach for Vascular Control and Repair of an Expanding Iatrogenic Femoral Artery Pseudoaneurysm J. Gorecka, J.F Chen, S. Shah, A. Dardik, R.J Guzman, N. Nassiri, Journal of Vascular Surgery Cases and Innovative Techniques (July 18, 2020) , doi: https://doi.org/10.1016/j.jv...